Higher PRKN expression was observed in male and stage III and IV HNSCC patients (Figures 8(h) and 8(i)), and higher FADD expression was found in patients with higher clinical stages and tobacco use (Figures 8(j) and 8(k)). The gene discussed is PRKN; the disease is head and neck squamous cell carcinoma.